Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.26 USD | -2.66% | -6.61% | -32.06% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 59% by 2026.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The company appears highly valued given the size of its balance sheet.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.06% | 588M | B- | ||
+73.27% | 12.38B | B- | ||
-21.89% | 7.61B | C+ | ||
+14.67% | 7.11B | C- | ||
+4.77% | 5.83B | B | ||
+11.77% | 5.35B | D+ | ||
+29.65% | 4.63B | - | ||
-18.88% | 4.02B | B- | ||
-42.48% | 2.16B | C | ||
+1.24% | 2.01B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SIBN Stock
- Ratings SI-BONE, Inc.